PedAM
Pediatric Disease Annotations & Medicines
| Disease | n syndrome |
| Phenotype | C0679466|cognitive deficits |
| Sentences | 10 |
| PubMedID- 22898099 | The cognitive deficits in down syndrome (ds) are attributed to an excessive hippocampal inhibition, which obstructs neuronal plasticity and normal learning and memory, a view which is largely based on studies of ts65dn mice, the best characterized mouse model of ds. |
| PubMedID- 21447382 | These results imply that alpha-tocopherol supplementation from an early stage may be an effective treatment for the cognitive deficits associated with down syndrome. |
| PubMedID- 22848844 | Indeed, cognitive deficits associated with angelman syndrome were reversed in a mouse model of the disorder by reducing the levels of camkii phosphorylated at thr305/306 [92]. |
| PubMedID- 21816951 | The use of mouse models to understand and improve cognitive deficits in down syndrome. |
| PubMedID- 24801365 | cognitive deficits in down syndrome (ds) have been linked to increased synaptic inhibition, leading to an imbalance of excitation/inhibition (e/i). |
| PubMedID- 22763378 | Increased corpus callosum volume in children with chromosome 22q11.2 deletion syndrome is associated with neurocognitive deficits and genetic polymorphisms. |
| PubMedID- 20305089 | Smith-lemli-opitz syndrome (slos) and lathosterolosis are malformation syndromes with cognitive deficits caused by mutations of 7-dehydrocholesterol reductase (dhcr7) and lathosterol 5-desaturase (sc5d), respectively. |
| PubMedID- 19962860 | Chromosome 22q11.2 deletion syndrome (22q11ds) is associated with cognitive deficits and morphometric brain abnormalities in childhood and a markedly elevated risk of schizophrenia in adolescence/early adulthood. |
| PubMedID- 21029075 | cognitive deficits in down syndrome: narrowing 'down' to olig1 and olig2. |
| PubMedID- 22541289 | Pathways to cognitive deficits in down syndrome. |
Page: 1